Zobrazeno 1 - 10
of 551
pro vyhledávání: '"Pro, B."'
Autor:
Horwitz, S., O'Connor, O.A., Pro, B., Trümper, L., Iyer, S., Advani, R., Bartlett, N.L., Christensen, J.H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W.S., Feldman, T., Menne, T., Belada, D., Illés, Á., Tobinai, K., Tsukasaki, K., Yeh, S.-P., Shustov, A., Hüttmann, A., Savage, K.J., Yuen, S., Zinzani, P.L., Miao, H., Bunn, V., Fenton, K., Fanale, M., Puhlmann, M., Illidge, T.
Publikováno v:
In Annals of Oncology March 2022 33(3):288-298
Autor:
Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens-Uwe Blohmer, Anna Maria Hage, Felix Fischer, Matthias Rose, Ulrike Grittner, Pimrapat Gebert, Julia Ferencz, Luis Pauler, Clara Breidenbach, Christoph Kowalski, on behalf of the PRO B Steering Board
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Despite the progress of research and treatment for breast cancer, still up to 30% of the patients afflicted will develop distant disease. Elongation of survival and maintaining the quality of life (QoL) become pivotal issues guidi
Externí odkaz:
https://doaj.org/article/e3fe8bd4bef046f78697eb2ee9833165
Autor:
Campo, E., Jaffe, E.S., Cook, J.R., Quintanilla-Martinez, L., Swerdlow, S.H., Anderson, K.C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A.L., Fend, F., Friedberg, J.W., Gaulard, P., Ghia, P., Horwitz, S.M., King, R.L., Salles, G., San-Miguel, J., Seymour, J.F., Treon, S.P., Vose, J.M., Zucca, E., Advani, R., Ansell, S., Au, W.Y., Barrionuevo, C., Bergsagel, L., Chan, W.C., Cohen, J.I., d'Amore, F., Davies, A., Falini, B., Ghobrial, I.M., Goodlad, J.R., Gribben, J.G., Hsi, E.D., Kahl, B.S., Kim, W.S., Kumar, S., LaCasce, A.S., Laurent, C., Lenz, G., Leonard, J.P., Link, M.P., Lopez-Guillermo, A., Mateos, M.V., Macintyre, E., Melnick, A.M., Morschhauser, F., Nakamura, S., Narbaitz, M., Pavlovsky, A., Pileri, S.A., Piris, M., Pro, B., Rajkumar, V., Rosen, S.T., Sander, B., Sehn, L., Shipp, M.A., Smith, S.M., Staudt, L.M., Thieblemont, C., Tousseyn, T., Wilson, W.H., Yoshino, T., Zinzani, P.L., Dreyling, M., Scott, D.W., Winter, J.N., Zelenetz, A.D.
Publikováno v:
Blood, vol. 140, no. 11, pp. 1229-1253
Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::9d6d6db77ed0140f6fbe09a0a2f5e110
https://serval.unil.ch/notice/serval:BIB_42E7F7A0538F
https://serval.unil.ch/notice/serval:BIB_42E7F7A0538F
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M, Illidge, T
Publikováno v:
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2022, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2021, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
Horwitz, S, O'Connor, O A, Pro, B, Trümper, L, Iyer, S, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Menne, T, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Zinzani, P L, Miao, H, Bunn, V, Fenton, K, Fanale, M, Puhlmann, M & Illidge, T 2021, ' The ECHELON-2 Trial : 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 3, pp. 288-298 . https://doi.org/10.1016/j.annonc.2021.12.002
BACKGROUND: For patients with peripheral T-cell lymphoma (PTCL), outcomes using frontline treatment with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP-like therapy are typically poor. The ECHELON-2 study demonstrated that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3bfa6d1173b5676a4c251f8a185f45
https://findresearcher.sdu.dk:8443/ws/files/199229320/1_s2.0_S0923753421048754_main.pdf
https://findresearcher.sdu.dk:8443/ws/files/199229320/1_s2.0_S0923753421048754_main.pdf
Autor:
Zinzani, P. L., Illidge, T., Horwitz, S. M., O'Connor, O. A., Pro, B., Iyer, S. P., Advani, R., Bartlett, N. L., Christensen, J. H., Morschhauser, F., Domingo-Domenech, E., Rossi, G., Kim, W. S., Feldman, T. A., Menne, T., Belada, D., Illes, A., Tobinai, K., Tsukasaki, K., Yeh, S-P., Huttmann, A., Savage, K. J., Yuen, S., Miao, H., Bunn, V., Fenton, K., Fanale, M. A., Puhlmann, M., Trumper, L.
Publikováno v:
Zinzani, P L, Illidge, T, Horwitz, S M, O'Connor, O A, Pro, B, Iyer, S P, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T A, Menne, T, Belada, D, Illes, A, Tobinai, K, Tsukasaki, K, Yeh, S-P, Huttmann, A, Savage, K J, Yuen, S, Miao, H, Bunn, V, Fenton, K, Fanale, M A, Puhlmann, M & Trumper, L 2021, ' ECHELON-2 (NCT01777152), A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN plus CHP VS CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMA: 5-YEAR RESULTS ', Haematologica, vol. 106, no. 10, Suppl. 3, pp. 3 . < https://doi.org/10.3324/haematol.2021.s3 >
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::f0965bd430d8c8753ef8c4c900cf6c95
https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65
https://portal.findresearcher.sdu.dk/da/publications/d13b2c46-5c6b-482c-b508-9f2b755dfe65
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Falchook, G.S., Vega, F., Dang, N.H., Samaniego, F., Rodriguez, M.A., Champlin, R.E., Hosing, C., Verstovsek, S., Pro, B. *
Publikováno v:
In Annals of Oncology June 2009 20(6):1080-1085
Autor:
Esmaeli, B. *, McLaughlin, P., Pro, B., Samaniego, F., Gayed, I., Hagemeister, F., Romaguera, J., Cabanillas, F., Neelapu, S.S., Banay, R., Fayad, L., Wayne Saville, M., Kwak, L.W.
Publikováno v:
In Annals of Oncology April 2009 20(4):709-714